Ergoteles LLC Laboratory Corp Of America Holdings Transaction History

Ergoteles LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$203.72 - $248.97 $6.38 Million - $7.79 Million	-31,298 Reduced 90.14%	3,425 $806,000
Q3 2022 Nov 14, 2022	BUY	$204.81 - $262.19 $7.11 Million - $9.1 Million	34,723 New	34,723 $7.11 Million
Q2 2022 Aug 12, 2022	SELL	$213.86 - $277.87 $946,544 - $1.23 Million	-4,426 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$259.82 - $298.18 $726,976 - $834,307	2,798 Added 171.87%	4,426 $1.17 Million
Q4 2021 Feb 14, 2022	SELL	$271.6 - $314.21 $429,128 - $496,451	-1,580 Reduced 49.25%	1,628 $512,000
Q3 2021 Nov 15, 2021	BUY	$274.82 - $308.34 $881,622 - $989,154	3,208 New	3,208 $903,000
Q2 2021 Aug 12, 2021	SELL	$251.87 - $278.14 $705,236 - $778,792	-2,800 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$204.88 - $255.03 $66,586 - $82,884	325 Added 13.13%	2,800 $714,000
Q4 2020 Feb 11, 2021	BUY	$186.91 - $214.42 $14,018 - $16,081	75 Added 3.13%	2,475 $504,000
Q3 2020 Nov 16, 2020	BUY	$167.03 - $201.3 $400,872 - $483,120	2,400 New	2,400 $452,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.1B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.